Conservative treatment of ovarian cancer: Safety, ovarian function preservation, reproductive ability, and emotional attitude of the patients in Saudi Arabia

Saudi Medical Journal

Volumn 32, Issue 9, 2011, Pages 913-918

  Sait, Khalid H ^a  

^a Aziz University   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CHILD; CLINICAL ARTICLE; CONSERVATIVE TREATMENT; EMOTIONALITY; FEMALE; FOLLOW UP; GERM CELL TUMOR; HUMAN; MEDICAL HISTORY; MENSTRUATION; OVARIAN PRESERVATION; OVARY CANCER; OVARY FUNCTION; PATIENT ATTITUDE; PATIENT IDENTIFICATION; PATIENT SAFETY; PREGNANCY; PRESCHOOL CHILD; REPRODUCTION; RETROSPECTIVE STUDY; REVIEW; SALPINGOOOPHORECTOMY; SAUDI ARABIA; SCHOOL CHILD; AGE; ARTICLE; ATTITUDE TO HEALTH; EMOTION; FERTILITY; NEOPLASM; OVARY; OVARY TUMOR; PHYSIOLOGY;

ADOLESCENT; ADULT; AGE FACTORS; ATTITUDE TO HEALTH; CHILD; CHILD, PRESCHOOL; EMOTIONS; FEMALE; FERTILITY; HUMANS; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; OVARY; RETROSPECTIVE STUDIES; SAUDI ARABIA; YOUNG ADULT;

EID: 84856365287     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. Pecorelli S, FIGO Committee of Gynecologic Oncology. 25th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2003; 3: 203-211.
2. Morice P, Wicart-Poque F, Rey A, El-Hassan J, Pautier P, Lhommé C, et al. Results of conservative treatment in epithelial ovarian carcinoma. Cancer 2001; 92: 2412-2418.
3. Talerman A. Blaunstein's pathology of the female genital tract. Germ cell tumors of the ovary. In: Kurman JK, editor. Blaunstein's Pathology of the Female Genital Tract. New York (NY): Springer; 2002. p. 967-1033.
4. Di Saia P, Cresman WT. Clinical gynecological oncology. 7th ed. Philadelphia (PA): Saunders Elsevier; 2007. p. 381-390.
5. Young RH, Scully RE. Ovarian sex cord-stromal tumours: recent advances and current status. Clin Obstet Gynaecol 1984; 11: 93-134.
6. Colombo N, Sessa C, Landoni F, Sartori E, Pecorelli S, Mangioni C. Cisplatin, vinblastine, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary. Obstet Gynecol 1986; 67: 265-268.
7. Powell JL, Connor GP, Henderson GS. Management of recurrent juvenile granulosa cell tumor of the ovary. Gynecol Oncol 2001; 81: 113-116.
8. Bridgewater JA, Rustin GJ. Management of non-epithelial ovarian tumours. Oncology 1999; 57: 89-98.
9. Morice P, Camatte S, Wicart-Poque F, Atallah D, Rouzier R, Pautier P, et al. Results of conservative management of epithelial malignant and borderline ovarian tumours. Hum Reprod Update 2003; 9: 185-192.
10. Tangir J, Shwartz PE. Fertility preservation in the management of germ cell ovarian cancer. CME J GynecolOncol 2003; 8: 117-120.
11. Duska LR, Chang YC, Flynn CE, Chen AH, Goodman A, Fuller AF et al. Epithelial ovarian carcinoma in the reproductive age group. Cancer 1999; 85: 2623-2629.
12. Zanagnolo V, Sartori E, Trussardi E, Pasinetti B, Maggino T. Preservation of ovarian function, reproductive ability and emotional attitudes in patients with malignant ovarian tumors. Eur J Obstet Gynecol Reprod Biol 2005; 123: 235-243.
13. International Federation of Gynecology and Obtetrics. Changes in definition of clinical staging for carcinoma of the cervix and ovary. Am J Obst Gynecol 1987; 156: 263-264.
14. Schover LR, Rybicki LA, Martin BA, Bringelsen KA. Having children after cancer. A pilot survey of survivors' attitudes and experiences. Cancer 1999; 86: 697-709.
15. Williams SD. Ovarian germ cell tumors: an update. SeminOncol 1998; 25: 407-413.
16. Gordon A, Lipton D, Woodruff JD. Dysgerminoma: a review of 158 cases from the Emil Novak Ovarian Tumor Registry. Obstet Gynecol 1981; 58: 497-504.
17. Mueller CW, Topkins P, Lapp WA. Dysgerminoma of the ovary: an analysis of 427 cases. Am J Obstet Gynecol 1950; 60: 153-159.
18. Lu KH, Gershenson DM. Update on the management of ovarian germ cell tumors. J Reprod Med 2005; 50: 417-425.
19. Zanetta G, Bonazzi C, Cantu M, Binidagger S, Locatelli A, Bratina G, et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors, J ClinOncol 2001; 19: 1015-1020.
20. Brewe M, Gershenson DM, Herzog CE, Mitchell MF, Silva EG, Wharton JT. Outcome and reproductive function after chemotherapy for ovarian dysgerminoma. J ClinOncol 1999; 17: 2670-2675.
21. Low JJ, Perrin LC, Grandon AJ, Hacker NF. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases. Cancer 2000; 89: 391-398.
22. Zanetta G, Chiari S, Rota S, Bratina G, Maneo A, Torri V, Mangioni C. Conservative surgery for stage I ovarian carcinoma in women of childbearing age. Br J ObstetGynaecol 1997; 104: 1030-1035.
23. Perrin LC, Low J, Nicklin JL, Ward BG, Crandon AJ. Fertility and ovarian function after conservative surgery for germ cell tumours of the ovary. Aust N Z J Obstet Gynaecol 1999; 39: 243-245.
24. Avery AJ, Betts DS, Whittington A, Heron TB, Wilson SH, Reeves JP. The mental and physical health of miners following the 1992 national pit closure programme: a crosssectional survey using General Health Questionnaire GHQ-12 and Short Form SF-36. Public Health 1998; 112: 169-173.
25. Hill A, Roberts J, Ewings P, Gunnell D. Non-response bias in a lifestyle survey. J Public Health Med 1997; 19: 203-207.
26. Perneger TV, Leplège A, Etter JF, Rougemont A. Validation of a French-language version of the MOS 36-Item Short Form Health Survey (SF-36) in young healthy adults. J ClinEpidemiol 1995; 48: 1051-1060.
27. Eaker S, Bergström R, Bergström A, Adami HO, Nyren O. Response rate to mailed epidemiologic quetionnaires: a population-based randomized trial of variations in design and mailing routines. Am J Epidemiol 1998; 147: 74-82.